Institutional Ownership Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE). We have compiled data on the 348 institutions that hold shares in the stock, with a total of 88.2 Million shares, which have been reported (via 13F filing form) to have a value of $2.92 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
10,132,728
shares
|
$335 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.79%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,603,352
shares
|
$185 Million
0.01% of portfolio
|
Q2 2024
Added 7.02%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
4,011,429
shares
|
$133 Million
0.01% of portfolio
|
Q3 2025
Added 1196.22%
|
|
|
Sands Capital Management, LLC
Arlington, VA |
Nov 13, 2025 Q3 2025 |
3,769,853
shares
|
$125 Million
0.33% of portfolio
|
Q3 2025
Reduced 4.4%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
3,692,487
shares
|
$122 Million
0.0% of portfolio
|
Q3 2025
Added 43.55%
|
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,258,266
shares
|
$108 Million
1.31% of portfolio
|
Q3 2025
Added 90.83%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,772,692
shares
|
$91.7 Million
0.68% of portfolio
|
Q2 2025
Added 75.92%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
2,310,174
shares
|
$76.4 Million
0.01% of portfolio
|
Q3 2025
Reduced 19.96%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 17, 2025 Q3 2025 |
2,167,729
shares
|
$71.7 Million
0.27% of portfolio
|
Q3 2025
Added 614.09%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
2,019,000
shares
|
$66.8 Million
1.82% of portfolio
|
Q3 2025
Reduced 11.37%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,945,129
shares
|
$64.3 Million
0.01% of portfolio
|
Q3 2025
Added 3.92%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,580,507
shares
|
$52.3 Million
0.0% of portfolio
|
Q3 2025
Reduced 7.73%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
1,546,101
shares
|
$51.1 Million
0.02% of portfolio
|
Q3 2025
Reduced 7.19%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 07, 2025 Q3 2025 |
1,545,279
shares
|
$51.1 Million
0.12% of portfolio
|
Q3 2025
Added 6.41%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 18, 2025 Q3 2025 |
1,458,187
shares
|
$48.2 Million
0.04% of portfolio
|
Q3 2025
Reduced 14.22%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
1,246,341
shares
|
$41.2 Million
2.51% of portfolio
|
Q3 2025
Reduced 10.4%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,150,169
shares
|
$38 Million
0.31% of portfolio
|
Q3 2025
Added 138.98%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,144,589
shares
|
$37.9 Million
0.23% of portfolio
|
Q3 2025
Added 101.81%
|
|
|
Frontier Capital Management CO LLC
|
Nov 14, 2025 Q3 2025 |
1,069,098
shares
|
$35.4 Million
0.32% of portfolio
|
Q3 2025
Added 103.46%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
983,715
shares
|
$32.5 Million
1.25% of portfolio
|
Q2 2025
Added 49.34%
|
|
|
Abrdn PLC
|
Nov 06, 2025 Q3 2025 |
973,656
shares
|
$32.2 Million
0.05% of portfolio
|
Q3 2025
Added 94.32%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
910,183
shares
|
$30.1 Million
0.0% of portfolio
|
Q3 2025
Added 42.47%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2025 Q3 2025 |
840,451
shares
|
$27.8 Million
0.03% of portfolio
|
Q3 2025
Added 599.24%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
794,849
shares
|
$26.3 Million
0.0% of portfolio
|
Q3 2025
Added 9.77%
|
|
|
Candriam S.C.A.
|
Nov 05, 2025 Q3 2025 |
754,714
shares
|
$25 Million
0.12% of portfolio
|
Q3 2025
Added 43.41%
|
|